Stock Options (Details Narrative) - USD ($)	1 Months Ended		6 Months Ended		12 Months Ended
	Sep. 19, 2023	Jul. 21, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2023	Jun. 30, 2022
Granted Options					35,000
Noncash stock base compensation expense		$ 684,900
Consultant fees	$ 8,000				$ 19,200
Grant Fair value					114,700
Stock-based compensation costs			$ 1,236,700		2,240,100	$ 2,350,600
Nonvested awards expected to be recognized			$ 1,945,300		$ 450,100	$ 3,187,300
Weighted-average period over which the nonvested awards expected to be recognized			1 year 1 month 20 days		10 months 13 days	1 year 6 months 3 days
2022 Plan
Common Stock, par value					$ 0.05
Options to purchase					1,750,000
Options previously granted					1,879,660
Exercise price					100.00%
Outstanding voting stock					10.00%
Granted Options			0	60,000	0
Grant Fair value			$ 0	$ 262,372	$ 0
Expired options					224,660
2012 Plan
Common Stock, par value					$ 0.05
Options to purchase					1,193,000
Options previously granted					57,000
Outstanding voting stock					100.00%
Granted Options			0	60,000	0
Grant Fair value			$ 0	$ 268,848	$ 0